The European Blueprint for Rare Diseases
ECMTF contributed to the Blueprint • October 2026 From fragmented initiatives to a coordinated EU Action Plan The European CMT…
ECMTF contributed to the Blueprint • October 2026 From fragmented initiatives to a coordinated EU Action Plan The European CMT…
AFM-Telethon has released the latest edition of its comprehensive document “Advances in Charcot-Marie-Tooth Disease”, offering patients, advocacy groups, and clinicians…
How a new study on rare disease advocacy groups reinforces the core mission of the European CMT Federation to bridge…
The European Charcot-Marie-Tooth Federation (ECMTF) highlights a pivotal step forward in the pursuit of effective treatments for Charcot-Marie-Tooth disease (CMT)….
Takeaways from the past PNS annual meeting The 2026 Annual Meeting of the Peripheral Nerve Society (PNS) took place in…
The development of new therapies is a highly structured and collaborative scientific process that requires significant time and investment to…
Why CMT must be part of the next European rare disease agenda Rare diseases remain one of Europe’s most complex…
The European CMT Federation (ECMTF) welcomes the addition of Muskelsvindfonden, the Danish Muscular Dystrophy Association, to its network. The organization…
Discover the deliverables and concrete actions stemming from the second European CMT Specialists Conference
The European CMT Federation is delighted to officially welcome Qianlixing CMT Support Home as our newest Associate Member. This collaboration…
A Comprehensive Analysis of the 2026 EURO-NMD Webinar Series on Charcot-Marie-Tooth Disease and the Structural Framework of Neuromuscular Education in…
A Comprehensive Report from the 2nd European CMT Specialist Conference The 2nd European CMT Specialist Conference was a landmark event,…